Oral mucosal pigmentation secondary to treatment with mepacrine, with sparing of the denture bearing area.
We report a case of oral mucosal pigmentation secondary treatment with mepacrine, with sparing of the denture bearing area. To our knowledge this phenomenon has not been reported since the association between antimalarial therapy and mucosal pigmentation was first described.
Martin
Timothy John Mitchell
TJ
Department of Oral and Maxillofacial Surgery, University Hospital Birmingham, Birmingham, UK. tjmmartin@btinternet.com
Sharp
Ian
I
D003829:Denture, Partial; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy; D008548:Melanosis / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced* / Q000473:pathology; D009061:Mouth Mucosa / Q000187:drug effects / Q000473:pathology; D021362:Palate, Hard / Q000187:drug effects* / Q000473:pathology; D011796:Quinacrine / Q000009:adverse effects*
D003879:Dermatologic Agents; D011796:Quinacrine